# 1st Gen Model McKesson Corporation Drugs, proprietaries, & sundries

  • $167.61Last close price
    at 26-jun-2017
  • Subscribe >>
  • 67.27% successful of 55 deals


Model's trade recommendations 2.05% Return for period

-5.94% Annual return

$35.30B Market Cap

β 1.15  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 2.05%
52wk return 13.62%
52wk Range
Sortino ratio -0.34
Sharpe ratio -0.29
Norm. RMSE 0.62%
Downside risk 14.54%
Volatility 17.06%
  • 1.12 (0.67%) Div (Yield)
  • BUY Analysts consensus recommendation

McKesson Corporation, the world's largest health care service and technology company, delivers unique supply and information management solutions that reduce costs and improve quality for its health care customers. The Company is organized under two operating segments: Health Care Supply Management and Health Care Information Technology.

Industry sector: Medical

Sector classification: Drugs, proprietaries, & sundries

Deep Learning based analysis and prediction model for McKesson Corporation (MCK) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for MCK model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 209M
P/E 12.98
Shares Outstanding 211M
% Held by Insiders 1.20%
% Held by Institutions 89.10%
EPS (last reported FY) $11.61
EPS (last reported Q) $3.39
EPS, estimated (last reported Q) $3.04
Total revenues $199 B
Net income $5 B